HEMOSTOD
HemostOD manufactures platelets on-demand from engineered stem cells.
HEMOSTOD
Social Links:
Industry:
Biotechnology Manufacturing
Founded:
2020-01-01
Address:
Lausanne, Vaud, Switzerland
Country:
Switzerland
Website Url:
http://www.hemostod.com
Total Employee:
1+
Status:
Active
Total Funding:
1.7 M CHF
Technology used in webpage:
Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS Person Schema Facebook Sharer
Similar Organizations
Alternative Plants
Hidden botanical treasures - active ingredients from rare medicinal plants made accessible by our plant stem cell technology
Batavia Biosciences
Batavia Biosciences focuses on accelerating the transition of biopharmaceutical product
Microdermis
Microdermis manufactures and markets skin care products for skin repair and protection, antimicrobial, and dental skin care.
Norman Biological Technology
Norman Biological Technology is a manufacturer of automated chemiluminescence system.
Current Employees Featured
Founder
Investors List
Orenok Holdings
Orenok Holdings investment in Seed Round - Hemostod
Official Site Inspections
http://www.hemostod.com
- Host name: 216.198.79.1
- IP address: 216.198.79.1
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Hemostod"
HemostOD – Engineered Platelets
HemostOD: a swiss-based preclinical company Founded in 2020, HemostOD is a biotech company based at the EPFL Innovation Park in Lausanne, Switzerland. We are a preclinical …See details»
HemostOD SA - Swiss Biotech
HemostOD is a seed financed start-up developing in-vitro human platelets. It has 10 staff, 8 of which are based at laboratories on the EPFL Innovation park in Lausanne. With operations …See details»
Hemostod - Crunchbase Company Profile & Funding
HemostOD manufactures platelets on-demand from engineered stem cells.See details»
HemostOD | VentureRadar
HemostOD’s product provides the only efficient alternative to blood donor platelet transfusions. We create a new source of platelets, manufactured on demand, to relieve blood banks and …See details»
HemostOD SA - BioAlps
Developed a donor-free, stem cell-derived, ex vivo platelets as a standardized alternative to blood donor platelet transfusions.See details»
HemostOD 2025 Company Profile: Valuation, Funding & Investors
Information on valuation, funding, cap tables, investors, and executives for HemostOD. Use the PitchBook Platform to explore the full profile.See details»
HemostOD - Products, Competitors, Financials, Employees, …
About HemostOD HemostOD focuses on the engineering and manufacturing of platelets for the healthcare sector. The company's offerings include the development of universal platelets for …See details»
HemostOD: platelets on demand - alliance-innovation.ch
HemostOD, an EPFL start-up supported by Alliance in obtaining an Innosuisse grant, has developed an innovative solution for producing platelets ex vivo, enabling large quantities to …See details»
HemostOD - ACI: Advise Connect Inspire
HemostOD engineers and manufactures platelets to unlock their potential in indications such as thrombocytopenia, tissue-targeted cargo delivery, and regenerative medicine.See details»
HemostOD | VentureRadar
HemostOD’s product provides the only efficient alternative to blood donor platelet transfusions. We create a new source of platelets, manufactured on demand, to relieve blood banks and …See details»
HemostOD
HemostOD enters EIT Health’s Gold Track Programme HemostOD has been recognized as a promising healthcare company by a jury of experts. The team will now receive tailored support …See details»
HemostOD et Emissium obtiennent le soutient de la FIT
HemostOD produces platelets rapidly and on a large scale Every year, 8 million platelet concentrates are transfused worldwide. This demand is growing by 5% a year, and is likely to …See details»
EPFL startup develops system for producing blood platelets on …
Jan 26, 2023 Blood platelets can be stored for only up to a week, and hospitals often run short of this life-saving resource. To help overcome this problem, an EPFL startup called HemostOD …See details»
HemostOD appoints an International Scientific Advisory Board – …
HemostOD SA EPFL Innovation Park – Bâtiment M Rue des Jordils, 1A 1025 St-Sulpice SwitzerlandSee details»
HemostOD - VentureRadar
HemostOD Unknown n/a HemostOD’s product provides the only efficient alternative to blood donor platelet transfusions. We create a new source of platelets, manufactured on demand, to …See details»
HemostOD will make platelets on demand - IO
Jan 28, 2023 The team behind HemostOD has spent two years developing the device. Élodie Dahan and Faouzi Khechana saw potential in an older technology sitting on the shelf at a …See details»
Hemostod - Funding, Financials, Valuation & Investors
HemostOD manufactures platelets on-demand from engineered stem cells.See details»
Hemostod - EU-Startups
HemostOD’s product provides the only efficient alternative to blood donor platelet transfusions. We create a new source of platelets, manufactured on demand, to relieve blood banks and …See details»
Microsoft Word - Press release 210902 - HemostOD
Resulting from over 10 years of research in microfluidic and stem-cell engineering, HemostOD’s unique bioreactor enables the manufacturing of ex-vivo platelets in just a few hours. …See details»
HemostOD receives CHF 100,000 from FIT for its on-demand …
Based at the EPFL Innovation Park, HemostOD has developed an innovative solution for ex vivo on-demand production of blood platelets, thus providing an efficient alternative to blood donor …See details»